Agenzia Italiana del Farmaco
home
Highlights
News
20 Mar 2026
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Remsima (infliximab)
16 Mar 2026
Transparency Lists
AIFA updates the Transparency Lists
13 Mar 2026
Safety of medicinal products
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 March 2026
09 Mar 2026
Technical and advisory committees
The Regulation on the organisation and functioning of the AIFA Scientific and Economic Committee has been published
27 Feb 2026
Press releases
AIFA supports the Rare Disease Day 2026
26 Feb 2026
Press releases
Duchenne and multiple myeloma: the NHS reimburses two innovative therapies
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology